11:07 AM EDT, 09/25/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were moving lower late Wednesday morning, declining 0.27% to 1,442.84 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical companies argenx (ARGX) and Genfit ( GNFT ) , which rose 4.3% and 3.6% respectively. They were followed by pharmaceutical company Ascendis Pharma ( ASND ) and internet advertising company Criteo ( CRTO ) , which increased 2.9% and 2% respectively.

The decliners from continental Europe were led by biotech firm Evaxion Biotech (EVAX) and biopharmaceutical company DBV Technologies ( DBVT ) , which fell 6.3% and 3.2% respectively. They were followed by semiconductor company Sequans Communications ( SQNS ) and software vendor SAP (SAP), which dropped 3% and 2.4% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and Amarin ( AMRN ) , which advanced 11% and 2% respectively. They were followed by biopharmaceutical company Bicycle Therapeutics ( BCYC ) and mining company BHP Group ( BHP ) , which were up 1.4% and 0.7% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana ( NCNA ) and Trinity Biotech ( TRIB ) 5.7% and 4% respectively. They were followed by biopharmaceutical company Adaptimmune Therapeutics ( ADAP ) and oil major BP (BP), which fell 2.8% and 2.5% respectively.